ArticleClinical and experimental medicine2025
Exploring the role of PANoptosis in idiopathic pulmonary fibrosis based on scRNA-seq and bulk-seq.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
PANoptosis is a novel form of programmed cell death that integrates pyroptosis, apoptosis, and necroptosis; in this study, we combined the single-cell RNA sequencing (scRNA-seq) dataset GSE227136 with transcriptome data to elucidate its role in idiopathic pulmonary fibrosis (IPF) pathogenesis. PANoptosis-related genes were compiled from GeneCards and published literature. Consensus clustering was used to identify distinct PANoptosis-related clusters of IPF in the GEO dataset based on filtered PANoptosis-related differentially expressed genes (PRDEGs). Specific hub genes were identified using weighted gene co-expression network analysis (WGCNA) and two machine learning methodologies, which were used to develop predictive models. The inflammatory programmed cell death score (PANoptosis score, Ps) for each IPF patient was calculated based on nine PRDEGs, followed by analyses of these PRDEGs' expression differences and their ROC curves. PRDEG expression was confirmed in murine pulmonary tissues using quantitative real-time polymerase chain reaction (qRT-PCR). We successfully identified nine PRDEGs and two distinct PANoptosis-related clusters with these PRDEGs. Using WGCNA and machine learning approaches, we constructed a nomogram with robust predictive capacity for diagnosis of IPF. In addition, immune infiltration analysis among different molecular groups and single cell analysis revealed that increased PANoptosis activity was closely associated with immune activation. Finally, results from qRT-PCR showed a significant increase in the expression of MLKL and AIM2 in the lung tissue of the IPF animal model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.